Lin Xichen: insider trades.
Lin Xichen reported 8 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Lin Xichen
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Structure Therapeutics Inc. (GPCR) | Officer · CHIEF SCIENTIFIC OFFICER | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Structure Therapeutics Inc. | M | 17,817 | $0.34 | 246,777 | Form 4 |
| 2026-09-01 | Structure Therapeutics Inc. | C | 17,817 | $0 | 228,960 | Form 4 |
| 2026-08-18 | Structure Therapeutics Inc. | C | 11,817 | $0 | 228,960 | Form 4 |
| 2026-08-18 | Structure Therapeutics Inc. | M | 11,817 | $0.34 | 240,777 | Form 4 |
| 2026-08-04 | Structure Therapeutics Inc. | M | 11,817 | $0.34 | 240,777 | Form 4 |
| 2026-08-04 | Structure Therapeutics Inc. | C | 11,817 | $0 | 228,960 | Form 4 |
| 2026-07-14 | Structure Therapeutics Inc. | M | 23,634 | $0.34 | 252,594 | Form 4 |
| 2026-07-14 | Structure Therapeutics Inc. | C | 23,634 | $0 | 228,960 | Form 4 |
Questions
What stock did Lin Xichen buy or sell?
Lin Xichen reported 8 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Lin Xichen the same person as other filers with this name?
This page covers SEC CIK 1962926 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/lin-xichen-1962926.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.